Pfizer-BioNTech today reported the first, early results of studies examining how well their vaccine protects against the fast-spreading Omicron variant. The companies say that adding a booster to the two-dose vaccine regimen neutralizes the Omicron variant in lab studies.
In a press release, the companies noted that while two doses of their COVID-19 vaccine show decreased protection again…
Read more